http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2186654-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-04
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-678
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-676
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-67
filingDate 1996-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_972bcd37f148b5e0be2eff002d6d8971
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d23a73a51a1e69abaa7cf49f9ded7a37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d15b0aac75134ecf947746339e5f8121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aace720286a2349febdd5e91b3a193d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ed53f2a999ebb26c43fd2fa82a678d
publicationDate 1997-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2186654-A1
titleOfInvention Phosphoric diester
abstract This invention provides a phosphoric diester of formula (?) which is available on di-esterification of phosphoric acid with L-ascorbic acid involving its 5-hydroxyl group and tocopherol involving its hydroxyl group or a pharmacologically acceptable salt thereof. (I) The compound of the invention can be used with advantage as an antioxidant (radical-scavenging) agent and a prophylactic and therapeutic agent for ischemic organ disorders (e.g. myocardial infarction, heart failure, arrhythmia, cerebral infarction, stroke (cerebral apoplexy), renal failure, etc.).
priorityDate 1995-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161462366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408961158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421328696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453559762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409089499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447774866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3718378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148549385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411319255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425998116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550161

Total number of triples: 54.